These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18044182)

  • 21. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
    Scharf M; Erman M; Rosenberg R; Seiden D; McCall WV; Amato D; Wessel TC
    Sleep; 2005 Jun; 28(6):720-7. PubMed ID: 16477959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
    Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
    Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T
    Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J; Trick L; Johnsen S; Roach J; Rubens R
    Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
    Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.
    Menza M; Dobkin RD; Marin H; Gara M; Bienfait K; Dicke A; Comella CL; Cantor C; Hyer L
    Mov Disord; 2010 Aug; 25(11):1708-14. PubMed ID: 20589875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eszopiclone (Lunesta) for treatment of transient and chronic insomnia.
    Wessell AM; Weart CW
    Am Fam Physician; 2005 Jun; 71(12):2359-60. PubMed ID: 15999875
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.
    McCall WV; Blocker JN; D'Agostino R; Kimball J; Boggs N; Lasater B; Haskett R; Krystal A; McDonald WM; Rosenquist PB
    J Clin Sleep Med; 2010 Aug; 6(4):322-9. PubMed ID: 20726279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL; McAllister PJ; Bilchik TR
    Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
    Sangal RB; Blumer JL; Lankford DA; Grinnell TA; Huang H
    Pediatrics; 2014 Oct; 134(4):e1095-103. PubMed ID: 25266438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
    J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Greater incidence of depression with hypnotic use than with placebo.
    Kripke DF
    BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.
    McCall WV; D'Agostino R; Rosenquist PB; Kimball J; Boggs N; Lasater B; Blocker J
    Sleep Med; 2011 Jun; 12(6):557-64. PubMed ID: 21601519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How well do Z-substances help in insomnia?].
    Baier PC
    MMW Fortschr Med; 2013 Jun; 155(12):30. PubMed ID: 23923306
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
    Greenblatt DJ; Zammit GK
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1609-18. PubMed ID: 23126273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia: a randomized controlled clinical trial.
    Gross CR; Kreitzer MJ; Reilly-Spong M; Wall M; Winbush NY; Patterson R; Mahowald M; Cramer-Bornemann M
    Explore (NY); 2011; 7(2):76-87. PubMed ID: 21397868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
    Zammit GK; McNabb LJ; Caron J; Amato DA; Roth T
    Curr Med Res Opin; 2004 Dec; 20(12):1979-91. PubMed ID: 15701215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.